Identi cation and validation of a novel cellular senescence-related lncrna prognostic signature for predicting immunotherapy response in stomach adenocarcinoma

HIGHLIGHTS

• who: August and collaborators from the Renmin Hospital of Wuhan, China have published the research work: Identi cation and validation of a novel cellular senescence-related lncRNA prognostic signature for predicting immunotherapy response in stomach adenocarcinoma, in the Journal: (JOURNAL)
• how: The results showed that TNFSF14 CD28 CD276 TNFSF18 CD80 CD40LG BTLA LAIR1 NRP1 CD86 TNFRSF8 CD200 CD48 PDCD1LG2 and CD200R1 genes were more highly expressed in the high-risk group while TNFSF9 and TNFRSF14 were lower expressed in the high-risk group . The results showed that STAD patients could be more clearly divided into . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.